Mitochondria and Mutagenesis
Mitochondria and Mutagenesis
批准号:
8272985
负责人:
KESHAV K SINGH
金额:
$16.77万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2013-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mitochondrial dysfunction is one of the hallmarks of cancer. However, very little is known about how
mitochondrial dysfunction leads to carcinogenesis. Our studies described in this proposal suggest a novel
role for mitochondria in protecting cells from nuclear genome mutagenesis, an important event in human
carcinogenesis. Using Saccharomyces cerevisiae as a model organism, we analyzed the consequences of
disrupting mitochondrial function on mutagenesis of the nuclear genome. We measured the frequency of
canavanine resistant colonies as an indicator of nuclear genome mutagenesis. Our data demonstrate that
mitochondrial dysfunction leads to mutation in the nuclear genome (i) in mutant strains lacking the entire
mitochondrial genome (rho¿ or p¿) or those with deleted mitochondrial DNA (rho" or p") (mitochondrial genetic
dysfunction, MGD) and (ii) when oxidative phosphorylation is blocked in wild type yeast by antimycin A
(mitochondrial metabolic dysfunction, MMD). The nuclear mutation frequencies in both MMD and MGD cells
were higher compared to untreated control and wild type cells respectively. MGD led to decreased
intracellular levels of ROS. In contrast MMD led to increased intracellular levels of reactive oxygen species
(ROS). We demonstrate that nuclear genome mutagenesis due to MGD is dependent on REV1, REVS or
REV7 gene products, all implicated in post-replication repair (PRR). However, nuclear genome mutagenesis
due to MMD does not involve REV1, REVS or REV7 genes. Furthermore, we provide evidence that Rtg2
protein (retrograde 2) involved in mitochondria-to-nucleus retrograde response pathway protect cells from
nuclear genome mutagenesis. Based on these observations we hypothesize that mitochondria protect
and employ multiple pathways to guard the nuclear genome against mutagenesis.
We propose 4 specific aims to test the proposed hypothesis. In all cases we have preliminary data that
provide the basis for the proposed specific aims. These specific aims are:1) Establish the role of
mitochondria-to-nucleus retrograde response pathway in nuclear genome mutagenesis due to mitochondrial
dysfunction 2) Determine whether compromised oxidative stress response leads to nuclear genome
mutagenesis due to mitochondrial dysfunction 3) Determine the role of post-replication repair pathway in
nuclear genome mutagenesis due to mitochondrial dysfunction 4) Determine the nature of nuclear genome
mutagenesis due to mitochondrial dysfunction Our proposed study should provide insight into the molecular
genetic mechanisms of nuclear genome mutagenesis due to mitochondrial dysfunction that is of fundamental
significance to human cancer and other diseases.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4103/1477-3163.50893
发表时间:
2009
期刊:
Journal of carcinogenesis
影响因子:
--
作者:
[Kulawiec M, Ayyasamy V, Singh KK]
通讯作者:
Singh KK
mtDNA depleter mouse for decoding mitochondrial regulation of diverse organs
-
批准号:10589093
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2022
-
负责人:KESHAV K SINGH
-
依托单位:
mtDNA depleter mouse for decoding mitochondrial regulation of diverse organs
-
批准号:10352486
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2022
-
负责人:KESHAV K SINGH
-
依托单位:
Mitochondria in Prostate Cancer Diversity
-
批准号:9901469
-
项目类别:
-
资助金额:$33.63万
-
财政年份:2016
-
负责人:KESHAV K SINGH
-
依托单位:
Mitochondria in Prostate Cancer Diversity
-
批准号:9237241
-
项目类别:
-
资助金额:$33.63万
-
财政年份:2016
-
负责人:KESHAV K SINGH
-
依托单位:
Mechanisms of arsenic-induced carcinogenesis
-
批准号:9280784
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:KESHAV K SINGH
-
依托单位:
Mechanisms of arsenic-induced carcinogenesis
-
批准号:8542997
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:KESHAV K SINGH
-
依托单位:
Mitochondrial DNA and Prostate Cancer in African American
-
批准号:8494189
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2013
-
负责人:KESHAV K SINGH
-
依托单位:
Mitochondrial DNA and Prostate Cancer in African American
-
批准号:8735897
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2013
-
负责人:KESHAV K SINGH
-
依托单位:
Arsenic Repression of GADD153 and Breast Cancer
-
批准号:8569744
-
项目类别:
-
资助金额:$22.04万
-
财政年份:2013
-
负责人:KESHAV K SINGH
-
依托单位:
Arsenic Repression of GADD153 and Breast Cancer
-
批准号:8723827
-
项目类别:
-
资助金额:$18.19万
-
财政年份:2013
-
负责人:KESHAV K SINGH
-
依托单位:
Tumorigenic role of mitochondria in African-American women
-
批准号:8135488
-
项目类别:
-
资助金额:$15.42万
-
财政年份:2010
-
负责人:KESHAV K SINGH
-
依托单位:
Tumorigenic role of mitochondria in African-American women
-
批准号:7992503
-
项目类别:
-
资助金额:$23.2万
-
财政年份:2010
-
负责人:KESHAV K SINGH
-
依托单位:
Mitochondria and Mutagenesis
-
批准号:7034869
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2006
-
负责人:KESHAV K SINGH
-
依托单位:
Loss of FLJ13639 Expression in Acute Leukemia
-
批准号:7470687
-
项目类别:
-
资助金额:$27.96万
-
财政年份:2006
-
负责人:KESHAV K SINGH
-
依托单位:
Loss of FLJ13639 Expression in Acute Leukemia
-
批准号:7902230
-
项目类别:
-
资助金额:$17.75万
-
财政年份:2006
-
负责人:KESHAV K SINGH
-
依托单位:
Mitochondria and Mutagenesis
-
批准号:7578207
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2006
-
负责人:KESHAV K SINGH
-
依托单位:
Loss of FLJ13639 Expression in Acute Leukemia
-
批准号:8272962
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2006
-
负责人:KESHAV K SINGH
-
依托单位:
Loss of FLJ13639 Expression in Acute Leukemia
-
批准号:7287348
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2006
-
负责人:KESHAV K SINGH
-
依托单位:
Mitochondria and Mutagenesis
-
批准号:7342428
-
项目类别:
-
资助金额:$30.99万
-
财政年份:2006
-
负责人:KESHAV K SINGH
-
依托单位:
Mitochondria and Mutagenesis
-
批准号:7198146
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2006
-
负责人:KESHAV K SINGH
-
依托单位:
海外基金